Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald F Weaver

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Critical Care Explorations|March 21, 2024
Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind StudyJohn Muscedere, David M Maslove, Christopher J Barden, et al.
Peerj|July 25, 2020
Small molecule therapeutics for COVID-19: repurposing of inhaled furosemideZhiyu Wang, Yanfei Wang, Prachi Vilekar, et al.
Current Alzheimer Research|January 30, 2024
Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's DiseaseKurt R Stover, Paul M Stafford, Andreea C Damian, et al.
Nature Communications|September 27, 2024
Computer-aided drug design to generate a unique antibiotic familyChristopher J Barden, Fan Wu, J Pedro Fernandez-Murray, et al.
Chemmedchem|March 24, 2021
A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) InhibitorsYong Zheng, Paul M Stafford, Kurt R Stover, et al.
Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolitesFelix S Meier-Stephenson, Vanessa C Meier-Stephenson, Michael D Carter, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Critical Care Explorations|March 21, 2024
Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind StudyJohn Muscedere, David M Maslove, Christopher J Barden, et al.
Peerj|July 25, 2020
Small molecule therapeutics for COVID-19: repurposing of inhaled furosemideZhiyu Wang, Yanfei Wang, Prachi Vilekar, et al.
Current Alzheimer Research|January 30, 2024
Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's DiseaseKurt R Stover, Paul M Stafford, Andreea C Damian, et al.
Nature Communications|September 27, 2024
Computer-aided drug design to generate a unique antibiotic familyChristopher J Barden, Fan Wu, J Pedro Fernandez-Murray, et al.
Chemmedchem|March 24, 2021
A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) InhibitorsYong Zheng, Paul M Stafford, Kurt R Stover, et al.
Journal of Medicinal Chemistry|August 23, 2016
Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum TrypanosomacidesStephanie Russell, Raphaël Rahmani, Amy J Jones, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolitesFelix S Meier-Stephenson, Vanessa C Meier-Stephenson, Michael D Carter, et al.
Pageof 13